BR0009102A - Compostos tiofenoetil tiouréia e uso no tratamento do hiv - Google Patents

Compostos tiofenoetil tiouréia e uso no tratamento do hiv

Info

Publication number
BR0009102A
BR0009102A BR0009102-2A BR0009102A BR0009102A BR 0009102 A BR0009102 A BR 0009102A BR 0009102 A BR0009102 A BR 0009102A BR 0009102 A BR0009102 A BR 0009102A
Authority
BR
Brazil
Prior art keywords
hiv
treatment
thiophenoethyl
thiourea compounds
drug
Prior art date
Application number
BR0009102-2A
Other languages
English (en)
Inventor
Fatih M Uckun
Taracad K Venkatachalam
Original Assignee
Parker Hughes Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst filed Critical Parker Hughes Inst
Publication of BR0009102A publication Critical patent/BR0009102A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSTOS TIOFENOETIL TIOURéIA E USO NO TRATAMENTO DO HIV". Apresenta-se novos compostos tiofenoetil tiouréia (TET) como inibidores de transcriptase reversa e agentes eficazes para tratamento de infecção por HIV, incluindo cepas de HIV mutantes, sensíveis à droga, resistentes à droga e resistentes a múltiplas drogas.
BR0009102-2A 1999-06-23 2000-06-23 Compostos tiofenoetil tiouréia e uso no tratamento do hiv BR0009102A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/338,685 US6124324A (en) 1999-06-23 1999-06-23 Thiophene-ethyl thiourea compounds and use
PCT/US2000/017361 WO2000078755A1 (en) 1999-06-23 2000-06-23 Thiophene-ethyl thiourea compounds and use in the treatment of hiv

Publications (1)

Publication Number Publication Date
BR0009102A true BR0009102A (pt) 2002-01-08

Family

ID=23325726

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009102-2A BR0009102A (pt) 1999-06-23 2000-06-23 Compostos tiofenoetil tiouréia e uso no tratamento do hiv

Country Status (14)

Country Link
US (1) US6124324A (pt)
EP (1) EP1194427B1 (pt)
JP (1) JP2003502423A (pt)
KR (1) KR20020012287A (pt)
CN (1) CN1196697C (pt)
AT (1) ATE233758T1 (pt)
AU (2) AU6539900A (pt)
BR (1) BR0009102A (pt)
CA (1) CA2375261A1 (pt)
DE (1) DE60001581T2 (pt)
ES (1) ES2195905T3 (pt)
IL (1) IL144874A0 (pt)
MX (1) MXPA01009283A (pt)
WO (2) WO2000078756A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001219672A1 (en) * 2000-10-18 2002-04-29 Parker Hughes Institute Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections
SE0100733D0 (sv) 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686428A (en) * 1989-04-07 1997-11-11 Aktiebolaget Astra Pharmaceutical composition
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses

Also Published As

Publication number Publication date
JP2003502423A (ja) 2003-01-21
CN1196697C (zh) 2005-04-13
ATE233758T1 (de) 2003-03-15
ES2195905T3 (es) 2003-12-16
KR20020012287A (ko) 2002-02-15
AU6539900A (en) 2001-01-09
EP1194427A1 (en) 2002-04-10
EP1194427B1 (en) 2003-03-05
AU5635800A (en) 2001-01-09
CN1356997A (zh) 2002-07-03
US6124324A (en) 2000-09-26
WO2000078755A1 (en) 2000-12-28
MXPA01009283A (es) 2002-04-10
IL144874A0 (en) 2002-06-30
DE60001581D1 (de) 2003-04-10
DE60001581T2 (de) 2004-02-19
WO2000078756A1 (en) 2000-12-28
CA2375261A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
BR0014282A (pt) Vacinas
ATE175608T1 (de) Vollbohrer
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
ATE377011T1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer
BR9916857A (pt) 4 heteroaril diarilaminas
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
TR200002759T2 (tr) Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı.
NO20031672D0 (no) Aza- og polyaza-naftalenylkarboksamider for anvendelse som HIV-integraseinhibitorer
NO20045152L (no) Ikke-nukleosid-reverstranskriptaseinhibitorer
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
TR200502508T2 (tr) IL-18 İnhibitörlerinin kullanımı.
TR200000272T2 (tr) Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
NO993670L (no) Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
IT1282673B1 (it) Derivati della camptotecina e loro uso come agenti antitumorali
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
ZA991029B (en) Composition and methods for treatment of hiv infections.
BR0009102A (pt) Compostos tiofenoetil tiouréia e uso no tratamento do hiv
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
ATE394378T1 (de) Phenanthridin -n- oxide
NO965591L (no) Kombinasjonsbehandling av HIV-infeksjon
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]